Phase III study supports use of canagliflozin for type 2 diabetes in children and adolescents
A Phase III, international, randomized clinical trial assessed the safety and efficacy of canagliflozin for the treatment of type 2 diabetes mellitus (T2DM) in children and adolescents.
Facebook Comments
https://www.sarkaridoctor.com/wp-content/uploads/2022/01/logo@2xx.png00aajahttps://www.sarkaridoctor.com/wp-content/uploads/2022/01/logo@2xx.pngaaja2025-08-05 12:34:092025-08-05 12:34:09Phase III study supports use of canagliflozin for type 2 diabetes in children and adolescents
